U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06386094) titled 'Cardiac Dysfunction in Patients With Non-alcoholic Fatty Liver Disease' on Sept. 19, 2023.
Brief Summary: Cirrhotic cardiomyopathy is seen as a blunted contractile responsiveness to stress, and/or altered diastolic relaxation with electrophysiological abnormalities, in absence of known cardiac disease. Left ventricular diastolic dysfunction (LVDD) is associated with risk of hepatorenal syndrome (HRS) , septic shock. , heart failure in the perioperative period following liver transplantation, and after trans-jugular intrahepatic portosystemic shunt (TIPS) insertion . The echocardiographic E/e' ratio is a predictor of survival in LVD...